DRAIN HF study
Enrolling By Invitation
99 years and younger
All
Phase
N/A
1 Location
Brief description of study
This is a prospective, multicenter,randomized, nonblinded study to evaluate the safety and effectiveness of the Aortix System versus standard of care medical therapy in patients hospitalized with ADHF and persistent congestion despite usual medical management and
who are not being considered for nearterm advanced HF therapy (i.e., LVAD
placement or heart transplant). Subjects will be randomized 1:1 to receive the
Aortix system or standard of care therapy.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: - 99 Years
-
Gender: All
TBD
Updated on
01 Aug 2024.
Study ID: 855304
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
